It is also imperative for future studies to continually validate LSD1 functionalities on the cancer-associated epigenome and its potential modulation of tumor immunogenicity in poorly immunosuppressive tumors, where it could give rise to novel strategies for cancer management. Here, KDM1A is linked to cancer.